Baudax Bio, Inc. Intellectual Property Contracts & Agreements
6 Contracts & Agreements
- License Agreements (6 contracts)
- Biological Materials License Agreement, dated August 26, 2019, by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute and... (Filed With SEC on August 16, 2023)
- Exclusive License Agreement, dated August 5, 2019, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Filed With SEC on August 16, 2023)
- Exclusive License Agreement, dated November 11, 2020, by and between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and TeraImmune, Inc (Filed With SEC on August 16, 2023)
- Exclusive Patent License Agreement, dated as of June 18, 2020, by and between the U.S. Department of Health and Human Services, as represented by the National Institute of Allergy... (Filed With SEC on August 16, 2023)
- Third Amendment to License Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC and Baudax Bio, Inc (Filed With SEC on August 21, 2020)
- Amendment to License Agreement, dated October 21, 2019, by and between Cornell University and Recro Pharma, Inc (Filed With SEC on February 13, 2020)
